ロード中...

Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the Details

PURPOSE: Intermittent androgen deprivation (IAD) has been widely tested in prostate cancer. However, phase III trials testing continuous androgen deprivation (CAD) versus IAD have reached inconclusive and seemingly contradictory results. Different design and conduct issues must be critically evaluat...

詳細記述

保存先:
書誌詳細
出版年:J Clin Oncol
主要な著者: Hussain, Maha, Tangen, Catherine, Higano, Celestia, Vogelzang, Nicholas, Thompson, Ian
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5242560/
https://ncbi.nlm.nih.gov/pubmed/26552421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.62.8065
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!